T3:O1 Genetics of obesity T3:O1-001 A ROLE FOR AGRP IN FOOD INTAKE AND BODY FATNESS
Charbonneau Chantal, Rankinen Tuomo, Bai Fulu, Bouchard Claude, Argyropoulos George Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA Aims: (1) Examine the effects of overnight starvation on the AgoutiRelated Protein (AgRP -a potent orexigenic peptide) mRNA levels centrally and peripherally in mice. (2) Evaluate the association of SNPs in the promoter of AgRP with human body fatness. Methods: (1) Two strains of mice, C57BL/6 and CAST, were used for overnight food deprivation. (2) The HERITAGE Family Study was used for the human genetics studies. Various cell lines were used for the functional studies of SNPs. Results: (1) Overnight food deprivation produced a signifi cant increase of AgRP mRNA not only in the hypothalamus, but also the adrenal, and the testes. The protein plasma levels of AgRP were also increased in both strains. (2) An SNP in the 5' UTR region of the gene, −3019G>A, was in complete Linkage Disequilibrium (LD) with SNP −38C>T, which we have previously reported to be associated with human body fatness. Functional studies showed that the −3019A allele had signifi cantly higher promoter activity. The net functional effect of the two SNPs is likely to be determined by the region containing the −38C>T SNP that had approximately 1000-fold higher activity than the region encompassing the −3019G>A SNP. Conclusions: (1) From the animal studies, we conclude that peripherally expressed AgRP might play a role in the regulation of food intake.
(2) From the human studies, we conclude that AgRP SNPs in the promoter region are associated with decreased fatness in humans. AgRP may be a useful target for interventional therapies to combat eating disorders and the epidemic of obesity. Aims: To study the links between the morphological changes of white adipose tissue (WAT) and the gene-expression variations during weight loss, which are unknown to humans. Methods: Subcutaneous WAT biopsies have been collected during intervention and 3 months later (weight loss mean: -22±6.8 Kg). The morphometrical analysis by light microscopy and electron microscopy were performed, as well as gene-expression analysis using pangenomic microarrays in 14 morbidly obese patients undergoing bariatric surgery. Results: Morphological analysis revealed a signifi cant regression of the hypertrophic cells (-4.5% of "big" adipose cells, p<0.05) and an increase (+ 3.8%, p<0.05) in "small" adipocytes, with a re-shaping of the extracellular matrix in obese subjects. The microarray technique led us to regroup by similarity of expression (clusterisation) several classes of genes, with an important mobilization of genes involved in the processes of the infl ammation (cytokines, chemokines, interleukins), and extracellular matrix remodelling in agreement with morphological observations. Conclusion: This is the fi rst study showing interrelationships between adipose tissue morphological changes and gene family variations after a drastic weight loss in obese subjects. Aims: Variants of the peroxisome proliferator-activated receptor γ2 (PPARγ2) gene region are reported to be associated to obesity and/or type 2 diabetes. We therefore aimed to investigate the promoter region of the PPARγ2 gene for novel variations, to examine novel promoter variants for linkage disequilibrium (LD) with known PPARγ2 gene variants, and to examine for associations to phenotypes related to obesity. Methods: We have screened the proximal 3371 bp of the putative PPARγ2 promoter using PCR-dHPLC and direct sequencing in 83 subjects with type 2 diabetes or severe obesity. The identifi ed SNPs were genotyped applying PCR-RFLP or Taqman 7900HT in 234 obese (BMI = 33.2 ± 2.5 kg/m2) and 323 non-obese (BMI = 21.7 ± 2.5 kg/m2) Danish men. Results: We identifi ed a total of 8 variants, 7 of which were novel, including -792A>G, -816C>T, -882T>C, -1505G>A, -1881C>T, -1884T>A, -2604T>C and -2953A>G, relative to the translation initiation site. The -1505G>A, -1881C>T, -816C>T and -2604T>C were in complete LD and in strong LD with the known Pro12Ala polymorphism (R2 = 0.929). Conclusions: In the PPARγ2 promoter region, we identifi ed several novel variants, some of which are tightly linked to previously reported variants within the coding region of the PPARγ2. Association studies to obesityrelated phenotypes are ongoing. Aims: The identifi cation of genes associated with obesity. Here we report the linkage for 6 genomic regions and association of 3 genes with obesity. Methods: In all, 168 families with at least two affecteds (BMI > 90 %) were studied. A whole genome scan based on direct physical mapping was performed at a <1 mb genome-wide resolution. Statistical analysis was performed to identify regions of excess IBD sharing, i.e. linked to obesity. SNP genotyping was carried out in the linked regions at 15 kb intervals. Denser SNP maps in genes were established by direct sequencing. Haplotypes were constructed and analyzed for association with obesity within families and cases and controls.
T3:O1-003

MORPHO-FUCTIONAL MODIFICATIONS AND GENE EXPRESSION IN WHITE ADIPOSE TISSUE OF OBESE PATIENTS UNDERGOING BARIATRIC SURGERY
T3
T3:O1-002 IDENTIFICATION OF 3 GENES ASSOCIATED WITH OBESITY IN REGIONS IDENTIFIED THROUGH A HIGH-DENSITY GENOME-WIDE LINKAGE SCAN
Results: Six regions showed signifi cant evidence for linkage. The average interval of the linkage region was 1.5 mb. Signifi cance levels ranged from p<10 -10 to p< 10 -5 for linked regions. SNP haplotype genotyping in 3 genes showed signifi cant evidence for association (p1< 0.02, p2< 0.009 and p3< 0.004). Single gene odds ratios were estimated and ranged from 1.57 to 168. Interestingly, all the three genes associated with obesity belong to the same pathway. Conclusion: We have used a new, quick, high-density, genome-wide method to identify regions linked to obesity. Haplotype analysis identifi ed 3 genes that are associated with obesity. These genes are interconnected functionally. Further studies are currently conducted to perform a multi-locus analysis including haplotypes from all three genes. Dpt. of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain
T3:O1-005 iNOS-DEFICIENT MICE SHOW REDUCED ADIPOSE TISSUE MASS AND HYPOLEPTINEMIA, BUT NORMAL ADIPONECTIN CONCENTRATIONS
Methods: Six-week-old male wild-type (WT) and iNOS-/-(KO) mice were used in the study (n=6 per group). Fasting plasma analyses included the determination of leptin and adiponectin. Leptin and adiponectin mRNA expression in epididymal WAT (EWAT) were measured by RT-PCR. Results: Body weight was not different among both groups (WT: 20.2 ± 0.6 g; KO: 20.2 ± 1.3; p=ns). However, the amount of EWAT in KO mice was reduced (WT: 0.22 ± 0.04 g; KO: 0.11 ± 0.01; p<0.05). Plasma concentrations of leptin (WT: 0.67 ± 0.17 ng/ml; KO: 0.23 ± 0.04; p<0.05) and leptin mRNA expression in EWAT (WT: 100 ± 18 arbitrary units; KO: 22 ± 8; p<0.01) were signifi cantly decreased in KO mice. Plasma adiponectin (WT: 8.36 ± 2.07 µg/ml; KO: 9.46 ± 1.62; p=ns) and adiponectin mRNA expression in EWAT (WT: 100 ± 27 a.u.; KO: 99 ± 24; p=ns) was not changed. Conclusions: Mice lacking iNOS exhibit a normal body weight, but reduced adipose mass accompanied by decreased hypoleptinemia. Aims: RMR is the largest component of the energy budget in humans. The literature is divided over whether RMR variation between individuals is related to obesity development and few studies have addressed this issue in animals. This study aimed to show if RMR effects could be revealed under high fat feeding in mice. Methods: Mice (C57BL/6J) received control 10 kcal% fat (n=14), medium 45 kcal% fat (n=50) or high 60 kcal% fat (n=50) diets (Research Diets, Inc.). RMR and fat mass (FM) (GE PIXImus TM DXA) were measured at treatment onset and at 6 months of age and mice were weighed weekly. Results: Body mass (BM) and FM gain were strongly infl uenced by diet (BM GLM: F 2,110 = 41.0, P < 0.001, FM GLM: F 2,110 = 36.7, P < 0.001). Weight gain averaged 9.5 g ± 0.54 g on the 60% fat diet (39% of baseline BM) and 0.7 g ± 0.33 g (3% of baseline BM) on control diet. Weight gain and RMR were not associated (GLM F 1,110 = 0.63, P = 0.43) and there was no interaction between RMR and dietary type (GLM F 2,108 = 0.13, P = 0.875). Results were no different when residual RMR, accounting for BM effects, was analysed. Conclusions: Individual variations in RMR are not a predisposing factor for weight gain in this mouse strain, suggesting that variations in energy expenditure due to RMR are well linked to dietary intake and therefore well compensated.
T3:R1 Human genes T3:R1-001 HUMAN OBESITY & INSULIN RESISTANCE: LESSONS FROM HUMAN SINGLE GENE DISORDERS
Stephen O'Rahilly Department of Clinical Biochemistry, University of Cambridge, UK We have applied a candidate gene approach to the study of two independent populations, with the extreme metabolic phenotypes of obesity and insulin resistance. A number of novel genetic disorders have been uncovered, several of which provide insights into the molecular regulation of human energy balance and insulin sensitivity. In the case of leptin defi ciency, leptin replacement therapy in fi ve children from three families has resulted in major improvements in adiposity, insulin sensitivity, endocrine and immune function. We have recently detected the second case of human prohormone convertase 1 defi ciency, and fi nd that small intestinal absorptive dysfunction is a major feature of this illness. Pathogenic mutations in the MC4R gene are found in 6% of our cohort. Genotype/phenotype correlations are evident in this group with subjects, with complete loss of function mutations having more severe obesity, greater height and higher food intake at a test meal than those with partially active mutant receptors. Within our insulin-resistant cohort, patients with dominant-negative mutations in PPAR gamma develop an exaggerated form of syndrome X with hypertension, dyslipidaemia, as well as fatty liver. We have found one family in which a mutation in PPAR gamma that does not act as a dominant negative only results in severe insulin resistance when it is present as a double heterozygote with a frameshift mutation in the gene encoding the muscle-specifi c regulatory subunit of protein phosphatase 1 (PPP1R3). Recently, we have detected a dominant-negative mutation in AKT2/PKB Beta that co-segregates with severe insulin resistance and diabetes in a three-generation pedigree. This represents the fi rst clear example of diabetes due to a postreceptor defect in insulin signal transduction.
T3:R1-003 CLUSTERING OF METABOLIC ABNORMALITIES IN OBESE INDIVIDUALS: THE ROLE OF GENETIC FACTORS Matti Uusitupa Department of Clinical Nutrition and Food and Health Research
Center, University of Kuopio, Finland Obesity, and in particular central obesity, is often associated with a multitude of metabolic abnormalities (metabolic syndrome), which include abnormalities in glucose and insulin metabolism, lipid disorders, elevated blood pressure, endothelial dysfunction and low-grade infl ammation. The prevalence of metabolic syndrome ranges from 15 to 30 % among different populations, and is highly dependent on the ethnic group, degree of obesity and level of physical activity. The characteristic feature of metabolic syndrome is insulin resistance, which is highly modifi able by lifestyles. On the other hand, it has been shown that genetic factors contribute to the development of both central obesity and insulin resistance. Besides genes involved in the development of (central) obesity, genes regulating glucose and lipid metabolism or blood pressure may play a role in clustering of metabolic abnormalities, ultimately increasing the risk of type 2 diabetes and cardiovascular diseases. A large number of genes may have an impact on these metabolic abnormalities, e.g. PPAR-gamma2, adiponectin and adiponectin receptor genes, ghrelin, UCPs, adrenergic receptor genes, genes regulating lipoprotein metabolism and those regulating steroid metabolism. In research into metabolic abnormalities in obesity, careful characterisation of phenotype and gene-environment interactions should be emphasised. Gene expression studies and functional genomics and proteomics provide new approaches to reveal the role of genetic factors in clustering of metabolic abnormalities in obesity. Like many other complex disorders, obesity results from genetic and environmental factors. Mitochondrial function is central to energy homeostasis. This review focuses on the role of obesity genes that affect mitochondrial function. Specifi cally, functional effects of sequence substitutions in genes encoding the uncoupling proteins and PGC-1α and their role in obesity will be discussed. Polymorphisms in the UCP2 gene have been implicated in the acute insulin secretory response to glucose, and may also have a role in the pathogenesis of atherosclerosis. The PGC-1α gene locus is associated with phenotypes of the metabolic syndrome such as obesity, type 2 diabetes and hypertension. These associations are physiologically plausible, since PGC-1α amplifi es the transcriptional responses of genes known or suspected to infl uence blood pressure regulation and energy, lipid and glucose metabolism.
T3:R2 What can we learn from animal studies T3:R2-001 THE METABOLIC SYNDROME FROM AN ADIPOCYTE PERSPECTIVE Antonio Vidal-Puig University of Cambridge, U.K.
Obesity and the Metabolic syndrome form probably the most lethal epidemic on the XXI century. In this session, we will review how genetically modifi ed mouse models have provided important new knowledge to understand and approach the metabolic syndrome. More specifi cally, we will focus on the interplay between white adipose tissue and skeletal muscle linking fatty acid synthesis with reciprocal effects on fatty acid oxidation. Work from our laboratory and others indicate that white adipocyte plays a key role in linking obesity to insulin resistance and type 2 diabetes mellitus, via facilitating the development of lipotoxicity in peripheral tissues. We propose a series of models to describe the process by which the adipose tissue could react to an energy-rich environment and responds depending on genetic and physiological factors, impacting on the functions of other peripheral tissues. We suggest that by examining hypotheses that encompass multiple organs and the partitioning of energy between these organs, a suitable strategy can be devised for the treatment of chronic effects associated with obesity. The mouse model to study complex traits such as obesity has several unique characteristics. Over 450 available inbred strains represent a large pool of genetic and phenotypic variations. The availability of the complete genomic sequence and genomic BAC libraries for several mouse strains makes identifi cation of a quantitative trait nucleotide (QTNs) a realistic goal. Finally, the availability of embryonic stem cell lines permits gene targeting by homologous recombination in the living mouse. The genetic analysis of complex traits consists of several steps. First, at least two strains with a contrasting phenotype of interest are chosen, the phenotype is quantifi ed and the F 1 hybrids, followed by backcross I (BC 1 ) or F 2 generation, are produced and their phenotype is quantifi ed. Then follows the genome-wide mapping of the segregating population or, at least, of the individuals representing the extreme ends of the phenotypic distribution. The quantitative trait loci (QTLs) are mapped using suitable software and their statistical signifi cance is tested. The fi nal step is the most diffi cult one: the QTL interval has to be restricted to 1 or 2 cM by preparing congenic lines and the QTL has to be identifi ed by positional cloning. The whole process is labor-intensive and time-consuming. To streamline it, alternative mapping systems were developed, including recombinant inbred strains (RIS), recombinant congenic strains (RCS), heterogeneus stock (HS) mice, advanced intercross lines (AIL) and, most recently, chromosome substitution strains (CSS). The construction and advantages of the newly constructed mouse inter-subspecies chromosome substitution strains in QTL mapping will be demonstrated.
T3:R2-003 APPROACHES TO MAPPING GENES OF COMPLEX DISEASES IN MICE
T3:R2-002
LIPOLYSIS WITHOUT HORMONE-SENSITIVE LIPASE R. Zechner, G. Hämmerle, J. Strauss, R. Zimmermann Institute of Molecular Biology, Biology and Microbiology, University of Graz, Heinrichstrasse 31A, 8010 Graz, Austria Unexpectedly, mice that lack hormone-sensitive lipase (HSL) do not accumulate excessive amounts of fat in adipose tissue. In contrast, mice older than 4 months exhibit reduced fat depots. These fi ndings suggest that the absence of HSL causes marked metabolic adaptations, including the downregulation of lipid synthesis as well as the alternative pathways of lipid catabolism. This presentation will summarize the current knowledge of lipid metabolism in adipose tissue in the absence of HSL.
